YHLO Showcases New Products at the 2025 ADLM Exhibition

YHLO Showcases New Products at the 2025 ADLM Exhibition

On July 29, 2025, Chicago, USA, hosted the annual global event for the in vitro diagnostics (IVD) industry—ADLM (American Diagnostic Laboratory Medicine). This year, YHLO made its international debut at the event, showcasing its latest innovations: the fully automated immunoblot analyzer Tenfly Phoenix and a compact automation line for immunology and biochemistry laboratories. For the first time, YHLO’s international team worked alongside the local Americas service team to welcome global partners.

At the exhibition, YHLO’s booth became one of the most eye-catching highlights of the event, drawing experts, scholars, and both new and old friends from all over the world to stop by for discussions. Through detailed on-site explanations and engaging demonstrations, the outstanding performance and innovative value of YHLO’s products earned widespread attention and high praise from the industry.

The Tenfly Phoenix Fully Automated Immunoblot Analyzer is designed for the diagnosis of autoimmune diseases, delivering a fully automated end-to-end workflow—from sample loading, incubation, and washing to reagent addition, drying, scanning, and final result output. This system not only improves the precision and efficiency of sample processing but also ensures the consistency and reliability of test results, significantly enhancing laboratory automation and overall testing efficiency.

The launch of Tenfly Phoenix not only demonstrates YHLO’s continuous innovation in immunoblot automation and provides global laboratories with more comprehensive and intelligent solutions for the precise diagnosis and treatment of autoimmune diseases. It further consolidates YHLO’s leading position in autoimmune diagnostics and enriches its product portfolio in this field.

A highlight of the exhibition was the visit of Dr. Julio Nieto Ramos, President of the Latin American Confederation of Clinical Biochemistry (COLABIOCLI). He highly praised YHLO’s contributions to the global advancement of intelligent laboratory testing—particularly its achievements in AI integration, product innovation, and market expansion. Dr. Ramos also expressed strong interest in further academic and industrial collaboration with YHLO in the Latin American market.

As the premier global event in clinical diagnostics since its inception in 1949, ADLM continues to serve as a leading platform for medical device showcases and new product launches. Leveraging this international stage, YHLO will keep demonstrating the innovation and clinical value of “Intelligent Manufacturing in China” to the world. Looking ahead, the company will further expand its international market layout, optimize its localized service system, and continue to provide global customers with high-quality in vitro diagnostic products and comprehensive solutions, contributing to the cause of human health.